Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review.
CONCLUSION: Premature CHD in SLE is multifactorial; modifiable variables should be monitored at frequent intervals to ensure prompt management. Disease-specific factors also affect the atherogenic process and should be evaluated regularly. Carotid ultrasonography may hold promise in predicting CVE in selected high-risk patients.
PMID: 26568591 [PubMed - as supplied by publisher]
Source: J Rheumatol - Category: Rheumatology Authors: Tselios K, Sheane BJ, Gladman DD, Urowitz MB Tags: J Rheumatol Source Type: research
More News: Antiphospholipid Syndrome | Cardiology | Cardiovascular | Coronary Heart Disease | Corticosteroid Therapy | Databases & Libraries | Heart | Heart Attack | Heart Disease | Hughes Syndrome | Hypertension | Lupus | Rheumatology | Smokers | Study